The Latest News, Updates and Resources
Cellares News
July 14th, 2021 – Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy
Forbes
July 28th, 2021 – Scalable Automation is Breaking the Bottleneck on Cell Therapy Manufacturing
Fierce Pharma
July 14th, 2021 – All aboard the Cell Shuttle: Cellares' cell therapy factory-in-a-box project attracts a 3rd partner in Poseida
GeneOnline
July 14th, 2021 – In Quest For Scalability in Cell Therapy Manufacturing, Cellares Partners with Poseida
Drug Discovery & Development
July 14th 2021 – Cellares and Poseida partnership aims to accelerate cell therapy manufacturing
Endpoints
July 14th 2021 – A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle
BioProcess International
July 14th 2021 – Poseida joins Cellares’ early-access cell therapy tech program
Fierce Pharma
May 6th, 2021 – Cellares raises $82M to drive work on cell therapy ‘factory-in-a-box’
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
May 5th, 2021 – Cellares Corporation, a life sciences technology company that automates cell…
Reuters
May 5th, 2021 – Cell therapy manufacturing tech startup Cellares raises $82 million
Endpoints
May 5th, 2021 – Focused on the cell therapy manufacturing bottleneck, Cellares turbocharges plans for ‘shuttle’ tech
Crunchbase
May 5th, 2021 – Cellares secures $82M Series B To Address Cell Therapy Manufacturing Obstacles. Life sciences technology…
MedCity News
May 5th, 2021 – Cellares gets $82M to make cell therapy manufacturing automated, scalable. Cell therapy manufacturing is currently…
BioProcess International
April 26th, 2021 – Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation…
Fabian Gerlinghaus featured in Medicine Maker Power List 2021
April 15th, 2021 – South San Francisco – Today, Cellares Co-Founder and CEO, Fabian Gerlinghaus was recognized in the 2021 Power List, celebrating…
Cellares Appoints Dr. Rodney L. Rietze to Advisory Board
February 11th, 2021 – South San Francisco – Cellares Corporation, a biotechnology company focused on revolutionizing cell therapy manufacturing…
CAR-T Sector Seeks Tech Boost to Meet Anticipated Demand
February 8th, 2021 – Products from Novartis and Gilead proved it was possible to win regulatory approval for chimeric antigen receptor T cell…
Spearheading a Paradigm Shift in Cell Therapy Manufacturing
January 25th, 2021 – Cell therapies are revolutionizing modern medicine. Where traditional treatment methods have failed, cell therapies…
Cellares Adds PACT Pharma to its Early Access Partnership Program
South San Francisco – January 8th, 2021 – Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing…
Einav Kraft joins Cellares as Vice President of Quality
December 2nd, 2020 – South San Francisco – Cellares Corporation, a biotechnology company focused on revolutionizing cell therapy manufacturing, announced…
Cellares Welcomes Fred Hutchinson Cancer Research Center Into Its Early Access Partnership Program
October 29th, 2020 – Cellares Corporation, a biotechnology company focused on revolutionizing cell…
Cellares – Evolving the Pharmaceutical Manufacturing Industry
October 29th, 2020 – Living with Stage IV cancer is a dual reality – one reality is counting your days left…
Mark Flower joins Cellares as Vice President of Business Development
May 8th, 2020 (South San Francisco) Cellares, an organization developing a next-generation cell therapy…
Company Logo
Cellares Fact Sheet
Founder Photos